Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Inflammation
Erschienen in: Inflammation 3/2018

28.02.2018 | ORIGINAL ARTICLE

Involvement of Alveolar Macrophages and Neutrophils in Acute Lung Injury After Scorpion Envenomation: New Pharmacological Targets

verfasst von: Hadjer Saidi, Julie Bérubé, Fatima Laraba-Djebari, Djelila Hammoudi-Triki

Erschienen in: Inflammation | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Androctonus australis hector (Aah) scorpion venom is well known to induce a systemic inflammatory response associated with cell infiltration in lung and edema formation. The present study investigate (i) in vivo the evolution of lung and systemic inflammation triggered by Aah venom and (ii) analyze in vitro the signaling cascade, upstream of inflammatory cytokine expression after Aah venom-stimulated mouse alveolar macrophage (MH-S), the main resident immune cells in the lung. The inflammation induced by Aah venom was assessed in mice through inflammatory cell count, nitric oxide metabolite, and lactate dehydrogenase (LDH) activity in blood, concordantly with neutrophil sequestration in tissue and lung histology. In the in vitro study, MH-S cells are stimulated with Aah venom in the presence of signaling pathway inhibitors, NG25 an inhibitor of transforming growth factor β-activated kinase (TAK1), PD184352 MAP kinase (MKK)1/2 inhibitor, BI605906 an inhibitor of IKκ-β (inhibitor of nuclear factor kappa B), and BIRB0796 an inhibitor of p38 MAPK. Obtained results showed that leukocyte transmigration is important in some area of the lung and is closely associated with systemic increase of nitric oxide and LDH. The in vitro study showed that Aah venom induce significantly an increase of the expression of TNF-α, IL-1β, and MIP-2 in MH-S cells. The pretreatment with inhibitors showed that cytokine increase involves TAK1, IKκ-β, and ERK1/2 pathways, similarly to Toll-like receptor activation. These findings highlight the contribution of alveolar macrophage and their secretory products to tissue damage and made of TAK1 and ERK1/2, an interesting target in scorpion envenomation.
Literatur
1.
Adi-Bessalem, S., D. Hammoudi-Triki, and F. Laraba-Djebari. 2008. Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and inflammatory response. Experimental and Toxicologic Pathology 60: 373–380.CrossRefPubMed
2.
Raouraoua-Boukari, R., S. Sami-Merah, D. Hammoudi-Triki, M.F. Martin-Eauclaire, and F. Laraba-Djebari. 2012. Immunomodulation of the inflammatory response induced by Androctonus australis hector neurotoxins: biomarker interactions. Neuroimmunomodulation 19: 103–110.CrossRefPubMed
3.
Saidi, H., S. Adi-Bessalem, D. Hammoudi-Triki, and F. Laraba-Djebari. 2013. Effects of atropine and propranolol on lung inflammation in experimental envenomation: comparison of two buthidae venoms. Journal of Venomous Animals and Toxins Including Tropical Diseases 19: 8.CrossRefPubMedPubMedCentral
4.
Bekkari, N., M.F. Martin-Eauclaire, and F. Laraba-Djebari. 2015. Complement system and immunological mediators: their involvements in the induced inflammatory process by Androctonus australis hector venom and its toxic components. Experimental and Toxicologic Pathology 67: 389–397.CrossRefPubMed
5.
Fukahara, Y., M. Reis, R. Dellalibera-Joviliani, F. Cunha, and E. Donadi. 2003. Increased levels of IL-1b, IL-6, IL-8, IL-10 and TNF-a in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon 41: 49–55.CrossRef
6.
Meki, A.-R., and Z.M. El-Dean. 1998. Serum interleukin-1β, interleukin-6, nitric oxide and α 1-antitrypsin in scorpion envenomed children. Toxicon 36: 1851–1859.CrossRefPubMed
7.
Hammoudi-Triki, D., E. Ferquel, A. Robbe-Vincent, C. Bon, V. Choumet, and F. Laraba-Djebari. 2004. Epidemiological data, clinical admission gradation and biological quantification by ELISA of scorpion envenomations in Algeria: effect of immunotherapy. Transactions of the Royal Society of Tropical Medicine and Hygiene 98: 240–250.CrossRefPubMed
8.
Taibi-Djennah, Z., and F. Laraba-Djebari. 2015. Effect of cytokine antibodies in the immunomodulation of inflammatory response and metabolic disorders induced by scorpion venom. International Immunopharmacology 27: 122–129.CrossRefPubMed
9.
Zoccal, K.F., C.A. Sorgi, J.I. Hori, F.W. Paula-Silva, E.C. Arantes, C.H. Serezani, D.S. Zamboni, L.H. Faccioli. 2016. Opposing roles of LTB4 and PGE2 in regulating the inflammasome-dependent scorpion venom-induced mortality. Nature Communications. 7.
10.
Christofidou-Solomidou, M., and V.R. Muzykantov. 2006. Antioxidant strategies in respiratory medicine. Treatments in respiratory medicine 5: 47–78.CrossRefPubMed
11.
Kobayashi, H., M. Kobayashi, T.A. Heming, A. Bidani, R.B. Pollard, and F. Suzuki. 1999. Cytokine production by rabbit alveolar macrophages. Differences between activated and suppressor cell phenotypes. Immunology letters 69: 339–346.CrossRefPubMed
12.
Matsunaga, K., T.W. Klein, H. Friedman, and Y. Yamamoto. 2001. Alveolar macrophage cell line MH-S is valuable as an in vitro model for Legionella pneumophila infection. American journal of respiratory cell and molecular biology 24: 326–331.CrossRefPubMed
13.
Wright, J.R. 2004. Host defense functions of pulmonary surfactant. Neonatology 85: 326–332.CrossRef
14.
Oberdörster, G., J. Ferin, R. Gelein, S.C. Soderholm, and J. Finkelstein. 1992. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environmental Health Perspectives 97: 193.CrossRefPubMedPubMedCentral
15.
Marshall, B.G., A. Wangoo, H.T. Cook, and R.J. Shaw. 1996. Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax 51: 1253–1261.CrossRefPubMedPubMedCentral
16.
Ware, L.B. 2006. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. In Seminars in respiratory and critical care medicine. Copyright© by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.; 2006: 337–349.
17.
Kaddache, A., M. Hassan, F. Laraba-Djebari, and D. Hammoudi-Triki. 2017. Switch of steady-state to an accelerated granulopoiesis in response to Androctonus australis hector venom. Inflammation 40: 871–883.CrossRefPubMed
18.
Petricevich, V.L., A.H. Cruz, F.I. Coronas, and L.D. Possani. 2007. Toxin gamma from Tityus serrulatus scorpion venom plays an essential role in immunomodulation of macrophages. Toxicon 50: 666–675.CrossRefPubMed
19.
Zoccal, K.F., C. da Silva Bitencourt, F.W.G. Paula-Silva, C.A. Sorgi, Kd.C.F. Bordon, E.C. Arantes, and L.H. Faccioli. 2014. TLR2, TLR4 and CD14 recognize venom-associated molecular patterns from Tityus serrulatus to induce macrophage-derived inflammatory mediators. PLoS One 9: e88174.CrossRefPubMedPubMedCentral
20.
Zoccal, K.F., C. da Silva Bitencourt, A. Secatto, C.A. Sorgi, Karla de Castro Figueiredo Bordon, S.V. Sampaio, E.C. Arantes, and L.H. Faccioli. 2011. Tityus serrulatus venom and toxins Ts1, Ts2 and Ts6 induce macrophage activation and production of immune mediators. Toxicon 57: 1101–1108.CrossRefPubMed
21.
22.
New, D.C., and Y.H. Wong. 2007. Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression. Journal of molecular signaling 2: 2.CrossRefPubMedPubMedCentral
23.
Kang, Y.J., J. Chen, M. Otsuka, J. Mols, S. Ren, Y. Wang, and J. Han. 2008. Macrophage deletion of p38α partially impairs lipopolysaccharide-induced cellular activation. The Journal of Immunology 180: 5075–5082.CrossRefPubMed
24.
Barton, G.M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300: 1524–1525.CrossRefPubMed
25.
Senger, K., V.C. Pham, E. Varfolomeev, J.A. Hackney, C.A. Corzo, J. Collier, V.W. Lau, Z. Huang, K. Hamidzhadeh, and P. Caplazi. 2017. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation. Science Signaling 10: eaah4273.CrossRefPubMed
26.
Zhang, Q., J. Huang, J. Yu, Z. Xu, L. Liu, Y. Song, X. Sun, A. Zhang, M. Jin. 2017. HP1330 contributes to Streptococcus suis virulence by inducing toll-like receptor 2-and ERK1/2-dependent pro-inflammatory responses and influencing in vivo S. suis loads. Frontiers in Immunology. 8.
27.
Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 78: 206–209.CrossRefPubMed
28.
Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248–254.CrossRefPubMed
29.
Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry 126: 131–138.CrossRefPubMed
30.
31.
Scherle, P.A., E.A. Jones, M.F. Favata, A.J. Daulerio, M.B. Covington, S.A. Nurnberg, R.L. Magolda, and J.M. Trzaskos. 1998. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. The Journal of Immunology 161: 5681–5686.PubMed
32.
Dumitru, C.D., J.D. Ceci, C. Tsatsanis, D. Kontoyiannis, K. Stamatakis, J.-H. Lin, C. Patriotis, N.A. Jenkins, N.G. Copeland, and G. Kollias. 2000. TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103: 1071–1083.CrossRefPubMed
33.
Martel, G., J. Bérubé, and S. Rousseau. 2013. The protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns (PAMPs). PLoS One 8: e59116.CrossRefPubMedPubMedCentral
34.
Valenca, S.S., F.S. Bezerra, A.A. Lopes, B. Romana-Souza, M.C.M. Cavalcante, A.B. Lima, V.L.G. Koatz, and L.C. Porto. 2008. Oxidative stress in mouse plasma and lungs induced by cigarette smoke and lipopolysaccharide. Environmental research 108: 199–204.CrossRefPubMed
35.
Skerrett, S.J., H.D. Liggitt, A.M. Hajjar, R.K. Ernst, S.I. Miller, and C.B. Wilson. 2004. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. American Journal of Physiology-Lung Cellular and Molecular Physiology 287: L143–L152.CrossRefPubMed
36.
Medjadba, W., M.F. Martin-Eauclaire, and F. Laraba-Djebari. 2016. Involvement of kallikrein-kinin system on cardiopulmonary alterations and inflammatory response induced by purified Aah I toxin from scorpion venom. Inflammation 39: 290–302.CrossRefPubMed
37.
Chair-Yousfi, I., F. Laraba-Djebari, and D. Hammoudi-Triki. 2015. Androctonus australis hector venom contributes to the interaction between neuropeptides and mast cells in pulmonary hyperresponsiveness. International Immunopharmacology 25: 19–29.CrossRefPubMed
38.
Murphy, K., P. Travers, and M. Walport. 2008. Janeway’s immunobiology. New York: Garland Science. Taylor & Francis Group.
39.
Driscoll, K.E. 2000. TNFα and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicology letters 112: 177–183.CrossRefPubMed
40.
De Filippo, K., R.B. Henderson, M. Laschinger, and N. Hogg. 2008. Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. The Journal of Immunology. 180: 4308–4315.CrossRefPubMed
41.
Eliopoulos, A.G., C.C. Wang, C.D. Dumitru, and P.N. Tsichlis. 2003. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40. The EMBO Journal 22: 3855–3864.CrossRefPubMedPubMedCentral
42.
Waterfield, M.R., M. Zhang, L.P. Norman, and S.-C. Sun. 2003. NF-κB1/p105 regulates lipopolysaccharide-stimulated MAP kinase signaling by governing the stability and function of the Tpl2 kinase. Molecular cell 11: 685–694.CrossRefPubMed
43.
Papoutsopoulou, S., A. Symons, T. Tharmalingham, M.P. Belich, F. Kaiser, D. Kioussis, A. O’Garra, V. Tybulewicz, and S.C. Ley. 2006. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Nature immunology 7: 606.CrossRefPubMed
44.
Cormet-Boyaka, E., K. Jolivette, A. Bonnegarde-Bernard, J. Rennolds, F. Hassan, P. Mehta, S. Tridandapani, J. Webster-Marketon, and P.N. Boyaka. 2011. An NF-κB–independent and Erk1/2-dependent mechanism controls CXCL8/IL-8 responses of airway epithelial cells to cadmium. Toxicological Sciences 125: 418–429.CrossRefPubMedPubMedCentral
45.
Sato, S., H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, K. Matsumoto, O. Takeuchi, and S. Akira. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nature Immunology 6: 1087.CrossRefPubMed
46.
Ninomiya-Tsuji, J., K. Kishimoto, A. Hiyama, J-i. Inoue, Z. Cao, and K. Matsumoto. 1999. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252–256.CrossRefPubMed
47.
McCubrey, J.A., L.S. Steelman, W.H. Chappell, S.L. Abrams, E.W. Wong, F. Chang, B. Lehmann, D.M. Terrian, M. Milella, and A. Tafuri. 2007. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773: 1263–1284.CrossRef
48.
Beinke, S., J. Deka, V. Lang, M. Belich, P. Walker, S. Howell, S. Smerdon, S. Gamblin, and S. Ley. 2003. NF-κB1 p105 negatively regulates TPL-2 MEK kinase activity. Molecular and Cellular Biology 23: 4739–4752.CrossRefPubMedPubMedCentral
49.
Beinke, S., M. Robinson, M. Hugunin, and S. Ley. 2004. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IκB kinase-induced proteolysis of NF-κB1 p105. Molecular and Cellular Biology 24: 9658–9667.CrossRefPubMedPubMedCentral
50.
Cho, J., M. Melnick, G.P. Solidakis, and P.N. Tsichlis. 2005. Tpl2 (tumor progression locus 2) phosphorylation at Thr290 is induced by lipopolysaccharide via an Iκ-B kinase-β-dependent pathway and is required for Tpl2 activation by external signals. Journal of Biological Chemistry 280: 20442–20448.CrossRefPubMed
51.
Das, S., J. Cho, I. Lambertz, M.A. Kelliher, A.G. Eliopoulos, K. Du, and P.N. Tsichlis. 2005. Tpl2/cot signals activate ERK, JNK, and NF-κB in a cell-type and stimulus-specific manner. Journal of Biological Chemistry 280: 23748–23757.CrossRefPubMed
52.
Bowie, A., and L.A. O’Neill. 2000. Oxidative stress and nuclear factor-κB activation: A reassessment of the evidence in the light of recent discoveries. Biochemical Pharmacology 59: 13–23.CrossRefPubMed
53.
54.
Alcamo, E., J.P. Mizgerd, B.H. Horwitz, R. Bronson, A.A. Beg, M. Scott, C.M. Doerschuk, R.O. Hynes, and D. Baltimore. 2001. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. The Journal of Immunology 167: 1592–1600.CrossRefPubMed
55.
Delaney, J.R., and M. Mlodzik. 2006. TGFβ activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle 5: 2852–2855.CrossRefPubMed
56.
57.
Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nature reviews immunology 4: 499–511.CrossRefPubMed
58.
Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annual review of immunology 21: 335–376.CrossRefPubMed
59.
Trinchieri, G., and A. Sher. 2007. Cooperation of Toll-like receptor signals in innate immune defence. Nature reviews Immunology 7: 179.CrossRefPubMed
60.
Kaisho, T., and S. Akira. 2006. Toll-like receptor function and signaling. Journal of allergy and clinical immunology 117: 979–987.CrossRefPubMed
61.
Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9: 143–150.CrossRefPubMed
62.
Bhattacharyya, S., C.K. Ratajczak, S.K. Vogt, C. Kelley, M. Colonna, R.D. Schreiber, and L.J. Muglia. 2010. TAK1 targeting by glucocorticoids determines JNK and IκB regulation in Toll-like receptor–stimulated macrophages. Blood 115: 1921–1931.CrossRefPubMedPubMedCentral
Metadaten
Titel
Involvement of Alveolar Macrophages and Neutrophils in Acute Lung Injury After Scorpion Envenomation: New Pharmacological Targets
verfasst von
Hadjer Saidi
Julie Bérubé
Fatima Laraba-Djebari
Djelila Hammoudi-Triki
Publikationsdatum
28.02.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0731-9

Weitere Artikel der Ausgabe 3/2018

Inflammation 3/2018 Zur Ausgabe

ORIGINAL ARTICLE

GTS-21 Protected Against LPS-Induced Sepsis Myocardial Injury in Mice Through α7nAChR

ORIGINAL ARTICLE

TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response

ORIGINAL ARTICLE

Feishu Acupuncture Inhibits Acetylcholine Synthesis and Restores Muscarinic Acetylcholine Receptor M2 Expression in the Lung When Treating Allergic Asthma

ORIGINAL ARTICLE

miR-140-5p/miR-149 Affects Chondrocyte Proliferation, Apoptosis, and Autophagy by Targeting FUT1 in Osteoarthritis

ORIGINAL ARTICLE

Effect of Soluble Epoxide Hydrolase in Hyperoxic Acute Lung Injury in Mice

ORIGINAL ARTICLE

Immunomodulatory Effects of CP-25 on Splenic T Cells of Rats with Adjuvant Arthritis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise